Parliamentary Privilege in Canada

Parliamentary Privilege in Canada

Author: Joseph P. Maingot

Publisher: McGill-Queen's Press - MQUP

Published: 1997-11-19

Total Pages: 431

ISBN-13: 0773567135

DOWNLOAD EBOOK

Joseph Maingot describes the parameters of the principal immunity enjoyed by Members of Parliament, that of freedom of speech, which is restricted to the context of a parliamentary proceeding and not beyond. He points out protections afforded members other than parliamentary privilege and the view of both the courts and the legislatures concerning parliamentary debates and proceedings as evidence in court. He also sets out in detail what the House of Commons considers to be and not to be a matter of privilege, as well as the corporate powers of the Houses of Parliament.


Titian Remade

Titian Remade

Author: Maria H. Loh

Publisher: Getty Publications

Published: 2007

Total Pages: 218

ISBN-13: 089236873X

DOWNLOAD EBOOK

This insightful volumes the use of imitation and the modern cult of originality through a consideration of the disparate fates of two Venetian painters - the canonised master Titian and his artistic heir, the little-known Padovanino.


Secrets of the Temple

Secrets of the Temple

Author: William Greider

Publisher: Simon and Schuster

Published: 1989-01-15

Total Pages: 804

ISBN-13: 0671675567

DOWNLOAD EBOOK

Reveals how the Federal Reserve under Paul Volcker engineered changes in America's economy.


We Hold this Treasure

We Hold this Treasure

Author: Steven E. Koop

Publisher:

Published: 1998

Total Pages: 200

ISBN-13:

DOWNLOAD EBOOK

Based Upon interviews and correspondence with more than four hundred former patients, We Hold This Treasure is the inspiring story of the first state-funded hospital in the United States to provide care for indigent, handicapped children.


Pharmaceutical R&D

Pharmaceutical R&D

Author:

Publisher: DIANE Publishing

Published: 1993

Total Pages: 380

ISBN-13: 9780788104688

DOWNLOAD EBOOK

Analyzes the costs, risks, and economic rewards of pharmaceutical R&D and the impact of public policy on both costs and returns. Examines the rapid increase in pharmaceutical R&D that began in the 1980s in the light of trends in science, technology, drug discovery, and health insurance coverage; Government regulation; product liability; market competition; Federal tax policy; and Federal support of prescription drug research. 12 appendices, including a glossary of terms.